Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bioasis Technologies Inc. > BTI:TSXV: Announces $200,000 Non-Brokered Private Placement
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(192)
•••
Comment by craighenryon Jan 29, 2021 7:28pm
105 Views
Post# 32426634

RE:RE:RE:RE:RE:BTI:TSXV: Announces $200,000 Non-Brokered Private Placement

RE:RE:RE:RE:RE:BTI:TSXV: Announces $200,000 Non-Brokered Private Placement
chrispi wrote: If some shareholders are so jaded from the past and just plain dumb to think a family office buying (a starter position?) shares in a relatively "thinly" traded stock at a price 25% ABOVE THE CURRENT MARKET PRICE is not a good thing, then Bioasis could cure brain cancer and they still would not be happy.


I may not agree with you on everything chrispi but you are spot on here. This definitely positive.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities